-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Alto Neuroscience, Maintains $37 Price Target

Benzinga·11/11/2026 17:45:42
Listen to the news
BTIG analyst Thomas Shrader reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $37 price target.